Lorazepam (Ativan). An intravenous sedative in podiatric surgery

1983 ◽  
Vol 73 (6) ◽  
pp. 307-310
Author(s):  
EA Gilman ◽  
M Borovoy
Keyword(s):  
1996 ◽  
Vol 35 (4) ◽  
pp. 344-349 ◽  
Author(s):  
Jeffery S. Deacon ◽  
Stuart J. Wertheimer ◽  
John A. Washington

2003 ◽  
Vol 42 (2) ◽  
pp. 68-76 ◽  
Author(s):  
Timothy P. Kalla ◽  
Alastair Younger ◽  
James A. McEwen ◽  
Kevin Inkpen
Keyword(s):  

CHEST Journal ◽  
2009 ◽  
Vol 135 (4) ◽  
pp. 917-922 ◽  
Author(s):  
Andrew H. Felcher ◽  
Richard A. Mularski ◽  
David M. Mosen ◽  
Teresa M. Kimes ◽  
Thomas G. DeLoughery ◽  
...  

2018 ◽  
Vol 11 (5) ◽  
pp. 444-450 ◽  
Author(s):  
Jemma H. Matthews ◽  
Alexander J. Terrill ◽  
Alex L. Barwick ◽  
Paul A. Butterworth

Background: The extent to which podiatric surgeons follow venous thromboembolism guidelines is unknown. The aim of this study therefore, was 2-fold: (a) to determine the rate of venous thromboembolism following podiatric surgery and (b) to investigate the factors that influence the use of thromboprophylaxis. Methods: Data from 4238 patients who underwent foot and ankle surgery over 2 years were analyzed. Venous thromboembolism within the first 30 days following surgery was recorded using the Australasian College of Podiatric Surgeons surgical audit tool. Logistic regression analyses were undertaken to determine the factors that influenced thromboprophylaxis. Results: Of the 4238 patient records, 3677 records (87%) provided complete data (age range 2-94 years; mean ± SD, 49.1 ± 19.7 years; 2693 females). A total of 7 venous thromboembolic events (0.2% rate) were reported. Operative duration and age (OR 12.63, 95% CI 9.47 to 16.84, P < 0.01), postoperative immobilization (OR 6.94, 95% CI 3.95 to 12.20, P < 0.01), and a prior history of VTE (OR 3.41, 95% CI 1.01 to 11.04, P = 0.04) were the strongest predictors of thromboprophylaxis. Conclusion: Podiatric foot and ankle surgery is associated with a low rate of venous thromboembolism. This may be due in part to the thromboprophylaxis regime implemented by podiatric surgeons, which closely aligns with current evidence-based guidelines. Levels of Evidence: Level II: Prospective cohort study


1991 ◽  
Vol 81 (2) ◽  
pp. 62-67 ◽  
Author(s):  
RG Yen ◽  
JA Giacopelli ◽  
DP Granoff ◽  
RJ Steinbroner

An introduction to the biodegradable Biofix rod for use in podiatric surgery is presented. Its application for Austin-type bunionectomies is described. The advantages and shortcomings are compared to traditional internal fixation. For procedures necessitating osteotomy stability, the Biofix rod is another option for the podiatric surgeon.


Sign in / Sign up

Export Citation Format

Share Document